November 29, 2016 / 8:20 AM / 9 months ago

BRIEF-Innovent Biologics raises $260 mln in series D financing

Nov 29 (Reuters) -

* Innovent Biologics, Inc. Raises USD $260 million in series D financing

* Innovent Biologics-Future Industry Investment Fund led financing, with China Life Private Equity Limited, Milestone, Ping An, Taikang Insurance Group

* Innovent Biologics - Co's existing international investors, specifically Legend Capital, Temasek and Hillhouse Capital, also participated in financing Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below